U.S. Markets closed

Array BioPharma Inc. (ARRY)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
11.32-0.15 (-1.31%)
At close: 4:00PM EDT
People also watch
EXELCLDXARQLFOLDPGNX
Full screen
Previous Close11.47
Open11.44
Bid10.65 x 500
Ask11.66 x 2500
Day's Range11.16 - 11.50
52 Week Range4.59 - 13.40
Volume2,932,588
Avg. Volume4,048,774
Market Cap2.18B
Beta1.64
PE Ratio (TTM)-15.72
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com9 days ago

    Mirati Skyrockets On Positive Data - Biotech Movers

    The San Diego firm is scheduled to present positive preliminary data for two clinical studies of sitravatinib in non-small cell lung cancer at a symposium in Chicago on Friday.

  • American City Business Journals10 days ago

    Colorado biotech plans $200 million stock offering

    A Boulder biotech said it's commenced an underwritten public offering of about $200 million of its stock. Array BioPharma Inc. said it's begun an offering of $175 million of shares of its common stock, and it's giving underwriters the option to buy up to an additional $26 million in shares. In the SEC filing, Array officials said the company's stock price will probably not remain stable.

  • 24/7 Wall St.10 days ago

    Array BioPharma Slides on Secondary Offering

    Array BioPharma saw its shares turn negative early on Thursday after the firm announced a secondary offering.